日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
30/06/2023 | Luye Life Sciences Group Ltd | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Luye Pharma Holdings Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | UBS Group AG | 1201(L) | -68,750,000(L) | HKD3.535(L) | 414,017,118(L) 368,053,174(S) | 11.01 9.78 |
30/06/2023 | 刘殿波 | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | Shorea LBG | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
30/06/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 218,500,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
28/06/2023 | 易方达基金管理有限公司 | 1001(L) | +6,631,000(L) | HKD3.519(L) | 192,746,000(L) | 5.12 |
28/06/2023 | UBS Group AG | 1013(L) 1402(S) | +300,554,500(L) +218,500,000(S) | 477,797,810(L) 365,647,890(S) | 12.70 9.72 | |
03/05/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Life Sciences Group Ltd | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Nelumbo Investments Limited | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Shorea LBG | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | 刘殿波 | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | 刘殿波 | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Pharma Holdings Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Ginkgo (PTC) Limited | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Life Sciences Group Ltd | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical International Co., Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Ginkgo (PTC) Limited | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Nelumbo Investments Limited | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Luye Pharma Holdings Ltd. | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 128,160,000(L) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
03/05/2023 | Shorea LBG | 14015(S) | +128,160,000(S) | 1,257,196,703(L) 200,861,950(S) | 33.42 5.34 | |
22/02/2023 | 刘殿波 | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Hillhouse Investment Management, Ltd. | 1213(L) | 552,324,108(L) | 14.68 | ||
22/02/2023 | Hillhouse Fund V, L.P. | 1213(L) | 552,324,108(L) | 14.68 | ||
22/02/2023 | Shorea LBG | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Nelumbo Investments Limited | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Ginkgo (PTC) Limited | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Luye Pharma Holdings Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
22/02/2023 | Hillhouse NEV Holdings Limited | 1213(L) | 552,324,108(L) | 14.68 | ||
22/02/2023 | Luye Life Sciences Group Ltd | 1213(L) | 1,257,196,703(L) 72,701,950(S) | 33.42 1.93 | ||
20/01/2023 | 梁民杰 | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | 张化桥 | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | 卢毓琳 | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
20/01/2023 | 宋瑞霖 | 12041(L) | -250,000(L) | 0(L) 0(S) | 0.00 0.00 | |
1 2 3 4 5 6 |
備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
(S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
(P) - 可供借出的股份 | |
即時報價更新時間為 24/12/2024 17:59 | |
港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
新聞
股票
期貨期權N
權證
ETF
A股
外匯黃金
加密貨幣
基金
MPF